For example, studies on the key metabolic enzyme ASM have found that various tricyclic antidepressants, such as desipramine and amitriptyline, can act as functional inhibitors of ASM, becoming a new treatment strategy for inflammatory bowel disease and multiple sclerosis [38]. This evidence concerns the gene SMPD1 and multiple sclerosis.